계명대학교 의학도서관 Repository

Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: Intravascular ultrasound results from ENDEAVOR III

Metadata Downloads
Author(s)
허승호
Alternative Author(s)
Hur, Seung Ho
Publication Year
2008
Abstract
Background The purpose of this study was to investigate the vascular response of zotarolimus-eluting stent (ZES)
and sirolimus-eluting stent (SES) using serial intravascular ultrasound (IVUS).
Methods Data were obtained from the Endeavor Drug-Eluting Coronary Stent System Versus the Center Siromlimus-
Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions (ENDEAVOR) III trial, a randomized study
comparing ZES and SES for the treatment of de novo native coronary artery lesions. Serial (baseline and 8-month follow-up)
IVUS was available in 258 patients (190 ZES, 68 SES).
Results At 8 months, ZES had greater percentage of neointimal volume index (ZES 1.1 ± 0.8 mm3/mm vs SES 0.2 ±
0.1 mm3/mm, P b .01), resulting in smaller lumen volume index (6.0 ± 2.0 mm3/mm vs 7.0 ± 2.1 mm3/mm, P b .05).
Zotarolimus-eluting stents showed larger IVUS-detectable neointimal coverage over stent surface (50.2% vs 10.5%, P b .01)
and greater mean neointimal thickness (0.19 ± 0.07 mm vs 0.10 ± 0.06 mm, P b .01). Zotarolimus-eluting stents had a
significantly lower incidence of late-acquired incomplete stent apposition.
Conclusions Zotarolimus-eluting stent is associated with a significantly greater amount of neointimal hyperplasia
compared with SES. This amount of hyperplasia in ZES is distributed throughout the stent at 8-month follow-up. (Am Heart J
2008;155:108-13.)
Department
Dept. of Internal Medicine (내과학)
Publisher
School of Medicine
Citation
American Heart Journal, Vol.155(1) : 108-113, 2008
Type
Article
ISSN
0002-8703
DOI
10.1016/j.ahj.2007.08.008
URI
http://kumel.medlib.dsmc.or.kr/handle/2015.oak/34915
Authorize & License
  • AuthorizeOpen
  • EmbargoForever
Files in This Item:

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.